Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases (Q34450313)

2 August 2017

1 reference

title

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Taylor PC

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Molecular Biotechnology

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

153-168

1 reference

https://scigraph.springernature.com/pub.10.1385/mb:19:2:153

2 August 2017

exact match

0 references

cites work

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

1 reference

12 December 2020

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

1 reference

12 December 2020

Role of cytokines in rheumatoid arthritis

1 reference

12 December 2020

Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors

1 reference

12 December 2020

Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

1 reference

12 December 2020

Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-

1 reference

12 December 2020

Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis

1 reference

12 December 2020

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

12 December 2020

Differential regulatory effects of adenosine on cytokine release by activated human monocytes

1 reference

12 December 2020

Circulating adhesion molecules in disease

1 reference

12 December 2020

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

12 December 2020

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

How important are T cells in chronic rheumatoid synovitis?

1 reference

12 December 2020

Structure of tumour necrosis factor

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

12 December 2020

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

12 December 2020

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

12 December 2020

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

What is the natural history of rheumatoid arthritis?

1 reference

12 December 2020

E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic

1 reference

12 December 2020

A human inhibitor of tumor necrosis factor alpha

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

Active and latent forms of transforming growth factor beta activity in synovial effusions

1 reference

12 December 2020

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade

1 reference

12 December 2020

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

12 December 2020

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

12 December 2020

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

The tumor necrosis factor ligand and receptor families.

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

12 December 2020

Interleukin-1, tumor necrosis factor and their specific inhibitors.

1 reference

12 December 2020

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

12 December 2020

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha

1 reference

12 December 2020

Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Human tumor necrosis factor. Production, purification, and characterization

1 reference

12 December 2020

The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice

1 reference

12 December 2020

Molecular cloning of the complementary DNA for human tumor necrosis factor.

1 reference

12 December 2020

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

12 December 2020

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

12 December 2020

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

1 reference

12 December 2020

Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever

1 reference

12 December 2020

Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis

1 reference

12 December 2020

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

1 reference

12 December 2020

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

12 December 2020

Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis

1 reference

12 December 2020

Receptor-mediated label-transfer assay (RELAY): a novel method for the detection of plasma tumor necrosis factor at attomolar concentrations.

1 reference

12 December 2020

Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge

1 reference

12 December 2020

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

1 reference

12 December 2020

Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7.

1 reference

12 December 2020

The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease.

1 reference

12 December 2020

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

12 December 2020

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

12 December 2020

Identifiers

DOI

10.1385/MB:19:2:153

1 reference

Dimensions Publication ID

2 August 2017

1017761237

0 references

Fatcat ID

release_4gmgrsh6enajlcm6ieutahxyem

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4gmgrsh6enajlcm6ieutahxyem

24 November 2022

mapped directly with Wikidata item

1 reference